Iván Horváth

Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

Pascal Vranckx, Marco Valgimigli, Peter Jüni et al. · The Lancet · 2018 · 785 citations · Full text

Medicine, Cardiology, Pharmacotherapy +16

Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial

Daniel J.F.M. Thuijs, A. Pieter Kappetein, Patrick W. Serruys et al. · The Lancet · 2019 · 638 citations · Full text

Medicine, Cardiology, Surgery +14

Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial

Stephen D. Wiviott, Eugene Braunwald, Carolyn H. McCabe et al. · The Lancet · 2008 · 450 citations

Medicine, Cardiology, Pharmacotherapy +17

Invasive validation of a new oscillometric device (Arteriograph) for measuring augmentation index, central blood pressure and aortic pulse wave velocity

Iván Horváth, Ádám Németh, Zsófia Lenkey et al. · Journal of Hypertension · 2010 · 375 citations

Medicine, Cardiology, Internal Medicine +16

Cardiopoietic cell therapy for advanced ischemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial

Jozef Bartúnek, André Terzic, Beth A. Davison et al. · European Heart Journal · 2016 · 183 citations · Full text

Medicine, Cardiology, Cell Biology +13